{"name":"Surface Oncology","slug":"surface-oncology","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQam83VmpUSmR6eHpENXZ2eHpvbWlKSlNvamtzUUVjdUNfWERDT3pCVmMwYjg3algtLWJVVS1EcnkzLXlyTkVocnZEYy11bnFCdm1hSXpuekZDcVNSYWVZUGU4eC1KMUxIWlg2MzUwQldEc0RVS3Z5am50RHdoeG1lOVZjNEh4LWlXWVlaYjhEcXJWX0dN?oc=5","date":"2026-03-12","type":"pipeline","source":"statnews.com","summary":"Cancer cells can ‘barf’ proteins onto their cell surface. That may create new targets for immunotherapies - statnews.com","headline":"Cancer cells can ‘barf’ proteins onto their cell surface. That may create new targets for immunotherapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQWFhOWS1VOGxxSWFNclR6MUo1QUI4T3g1LWZqWFIwNl9abnB3dlRXUnQtQ0pzWnJsZ256X0tvMkZuLURsQ0M2OFI0VW81MmRCOEctV042eUU1UUE4VzhrUHFmbzlIeUZzcUZuX3hYUktXZVRJb1pHQnFaaEhobURQaFFFS3NiQ2ZIZXNxVFNNQzA?oc=5","date":"2026-02-05","type":"deal","source":"The Pharma Letter","summary":"Coherus Oncology announces deal with J&J - The Pharma Letter","headline":"Coherus Oncology announces deal with J&J","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQSVJJNENleHJ2cXI3NnpDbnkya1FoUDR1S2tCMS1PWEFQcXhRTW43Y2FVVjNSd3NPV1RxZC0yT2NDXzRIeWxBc0t2T0x3WnNMdjl5NTZ2b3VvTWtrLVkyM0E3ZGxkb0tGX0hyUW9EZDRaeVFpby1VOS02clRoeE1sQ1dVV0c4WkJTUFA3clVyRUtPOFFQbXJKZkZxck5VVUFUX0RHU3Z1X0dCTnBvODJjeGZyQm13aDhyQ0ZTZVpPUUk1TDVsdWhMYnptTlgtdw?oc=5","date":"2026-01-07","type":"deal","source":"Inside Precision Medicine","summary":"Shine On: DISCO Licenses Novel AND-Gated Cancer Target to Amgen - Inside Precision Medicine","headline":"Shine On: DISCO Licenses Novel AND-Gated Cancer Target to Amgen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNWU1uUGRZSGdPc3pXNTRlZlltUndFQ1JRdnZNYWozbS12RWYxa3RCa0taQ3NJUVZhMGhKa09zOWJpY1N6OENMSGt5VUJEUUxhSmM4R0lQQjNKOGRudy1kM2tKUGQ5Tzc0MHBCQmJzX3IwWTI0eEFLUTY2RWIxZ3hnQVQ1djVmSzg?oc=5","date":"2026-01-07","type":"pipeline","source":"Fierce Biotech","summary":"Amgen dances with Disco in $618M cancer target pact - Fierce Biotech","headline":"Amgen dances with Disco in $618M cancer target pact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOLW1oRktiNzRHNUo5ZFFpRzlMTXduYTY0SEF6LUxkVHdGNF9rSkgwRlRDODE2a1dYeDA1azNKOFJYd09idGRHRjY5aHIxUnN3MXdmVm81Z3JFOVJGVExremxJTGpDODU5eGJNYmFNQ09tSFJZMXpXY3hTb0xqcmFmUklENWVhQjNBekdJYkJUeFV4OFd5ZHlUeGEyQnpmYW5tcWRPems5ZTdHanlwM2xMUlZUQQ?oc=5","date":"2025-10-29","type":"regulatory","source":"Fierce Biotech","summary":"GSK abandons hopes for CD226 cancer therapies, dropping remaining phase 2 assets - Fierce Biotech","headline":"GSK abandons hopes for CD226 cancer therapies, dropping remaining phase 2 assets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOXzBwZm54ZnJSNl94V2xwUmQ5WTA2SWlyaGZRTGdqOEIzcU4xRXBKM01zWlQ1SGtnYTVBaUtsRWtfVjBmOWM5QmdRTnJpeE5xcE1tdU9Xdktid3FRUkZvakNaampHcjltT0pmRmlTemlEanh4SzNDN0xkbkVEdnpSTzk5YnBEcXhVN0pkRWoyQmJFeDFyUnE3Nm5R?oc=5","date":"2025-09-26","type":"pipeline","source":"Targeted Oncology","summary":"Considering the Impact of Sequencing in Frontline RCC Therapy - Targeted Oncology","headline":"Considering the Impact of Sequencing in Frontline RCC Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE93bDlkUU9sMUlBbEg0UUlPWU5YNVVaOXBlSGNiZ3JCcDFCOFhTelhCbkpKeEJaTXR3SnlydzA0eGVQSXZmY09GTVlPdDhFWEM4eG1F?oc=5","date":"2025-09-18","type":"pipeline","source":"FirstWord Pharma","summary":"Immuto is scouring the surface of cancer cells for conformationally unique targets - FirstWord Pharma","headline":"Immuto is scouring the surface of cancer cells for conformationally unique targets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5kUy1BbWhmMlpZTzNMV1EyaG5YZjhJYWhHQ19ZbFJJS1RIVjNXZWtkdUtBR2g0bk1JazZ5UVYySWN3NW1wcXBHZGMzNkRDRzkwRHlGV3ctWFJjNGJtWEJlQjJhRExSOGpIWTdpWUFmNlJYQW1pSGUtMVdHbGo?oc=5","date":"2023-09-11","type":"deal","source":"Pharmaceutical Technology","summary":"Coherus acquires immuno-oncology company Surface - Pharmaceutical Technology","headline":"Coherus acquires immuno-oncology company Surface","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPLWkyeXU4YkdOUGpqR0VUQm0yRU4xZFZTMXFSMUJiVXpBMkNXM1pLd1piaW5tR0J3cEZBSE50WkdFYTlMX2Rra1hCRkVRcy02OXBqQW9YZy10MW5mMUJSdWlXMzV6eGhWY3RJWERjcFJKUGxSVWVuNFJOT3I0WHJ6clF2TlhEclNudEtZMkYyNUdZdGlUWlBZ?oc=5","date":"2023-09-08","type":"pipeline","source":"Yahoo Finance","summary":"Coherus Completes Surface Oncology Acquisition - Yahoo Finance","headline":"Coherus Completes Surface Oncology Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOTGIzWWRnVnNrUkVDQmZsc1JpU205ME9wdlU3aGdiZ3FzRDkyZ1l4bFBfTEtFajViSVVZVy1rZnlUWWtNaWtLMENxRHloT0pyc2diNzNYb3FGWnd5OU1GY0dyNUM3enVpeF9MUzcxYjl3Y1MzX0Z1TnFMaENvbk54MXdKeXl4M3NURzF0SklCRm85MmI0VzQ3aQ?oc=5","date":"2023-06-16","type":"deal","source":"BioPharma Dive","summary":"Coherus doubles down on immuno-oncology with latest deal - BioPharma Dive","headline":"Coherus doubles down on immuno-oncology with latest deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOdzRsNTZVanRYVlB4ODY1UUpGdEtfNnhqOVZYZWFPY09nRFpSUUZBSXJvd3JsSFdaMVVra2dkS0FiVVFZQXRJbEtuLWIwUzBFd19kWWgwb2FkZm9Odkc2RTNwSlZpeDFVMzIyWldxNW4tUHVqb2tYSXF2eDlYSGdHR2ZQa24yRDNRT0w5VXdoVGVqb3gxbUE?oc=5","date":"2023-06-16","type":"pipeline","source":"BioSpace","summary":"Coherus Expands Portfolio with $65M Acquisition of Surface Oncology - BioSpace","headline":"Coherus Expands Portfolio with $65M Acquisition of Surface Oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQTnQyT1gwZ0hUWnpMUUVsaWNIWHpZeXZkTVRVWVRNaGpxTm5DbGJQMnUyQ1NQbjRVMV9CQm1sakZ3ZU9URkoxRlNyWVNVcmt5STF0eENBdXlvZHl2OUdsaTlhbEh5SUU1VGRiMEpiaU9vSnk2UFdsczdQbjJHX3FBejVubHJ3RTJWRngzd211XzVWTV9wX0p2VA?oc=5","date":"2022-11-30","type":"pipeline","source":"Pharma Voice","summary":"Woman of the Week: Surface Oncology’s Dr. Alison O’Neill - Pharma Voice","headline":"Woman of the Week: Surface Oncology’s Dr. Alison O’Neill","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}